“Is this going to have a big effect on our business model? No, because we did not develop this product for the Indian market, let’s be honest. We developed this product for Western patients who can afford this product, quite honestly. It is an expensive product, being an oncology product.” ~ Marijn Dekkers, Bayer Chief Executive Officer […]
Indian pharmaceutical companies cannot be judged by American standards. – GN Singh, Drug Controller General of India [source]
If you are looking for one reason for the mess that the Indian pharma industry is in, you do not need to look further than the statement above. This is a statement made by the head of the body responsible for ensuring the quality of drugs manufactured and sold in the country.
Surprisingly, this is something that I have discussed with two different people in the last 24 hours. One thing that an engineering college education does to you is make you very emotionally inadequate. All we can do is think logically, brushing aside all emotions, and makes us quant jocks in real life too. I was […]